HLA DSA-SAB Class I IgG Antibodies with C1q Screen Test sale cost 7960 AED
Gastrointestinal Cancer Gene Panel Test sale cost 7200 AED Gastrointestinal Cancer Gene Panel Test Cost 9,600 د.إ Original price was: 9,600 د.إ.7,200 د.إCurrent price is: 7,200 د.إ.
Microarray 180K AFCVSCBPOCPB Test sale cost 7020 AED Microarray 180K AFCVSCBPOCPB Test Cost 7,800 د.إ Original price was: 7,800 د.إ.7,020 د.إCurrent price is: 7,020 د.إ.
Sale!

HLA DSA-SAB Class I IgG Antibodies with C1q Screen Test Cost

Original price was: 8,840 د.إ.Current price is: 7,960 د.إ.

-10%

The HLA DSA-SAB Class I IgG Antibodies with C1q Screen Test is a specialized diagnostic procedure designed to identify specific antibodies in the human body that can play a crucial role in organ transplant compatibility and rejection. HLA stands for Human Leukocyte Antigen, a marker found on most cells in the body, which the immune system uses to recognize which cells belong in the body and which do not. DSA refers to Donor-Specific Antibodies, which are antibodies that develop against the antigens of the donor organ. The presence of these antibodies can lead to transplant rejection.

This test specifically targets Class I IgG antibodies, which are a type of antibody involved in the immune response, along with a C1q screen. The C1q component is part of the complement system, which helps antibodies clear pathogens from an organism. The C1q screen is used to determine if the detected antibodies are likely to activate the complement system, which can lead to a higher risk of organ rejection.

The test is available at DNA Labs UAE, a leading facility for genetic and specialized tests. The cost of the HLA DSA-SAB Class I IgG Antibodies with C1q Screen Test is 7960 AED. This test is particularly important for patients undergoing organ transplantation, as it helps in assessing the risk of transplant rejection and in managing post-transplant care to improve the chances of success and longevity of the transplant.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test

Test Name: HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test

Test Components: IgG antibodies against HLA class I molecules, C1q-fixing antibodies

Test Price: 7960.0 AED

Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Provide brief clinical history and HLA typing report of Donor/Donors if Pre or Post transplantation sample.

Report Delivery: 10-12 days

Method: Luminex X-Map technology

Test Type: Transplantation pathology

Doctor: Nephrologist, Hematologist

Test Department: DNA Labs UAE

Pre Test Information: Provide brief clinical history and HLA typing report of Donor/Donors if Pre or Post transplantation sample.

What is the HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test?

The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is a laboratory test used to detect the presence of specific antibodies in the blood that can cause rejection of transplanted organs. This test measures the level of IgG antibodies against human leukocyte antigen (HLA) class I molecules and screens for the presence of C1q-fixing antibodies. C1q is a protein that binds to IgG antibodies and activates the complement system, leading to tissue damage and rejection of the transplanted organ.

Why is the HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test performed?

The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is typically performed before and after organ transplantation to monitor the patient’s immune response to the transplanted organ. If the test shows the presence of high levels of HLA antibodies or C1q-fixing antibodies, it indicates an increased risk of rejection and the need for closer monitoring and treatment.

How is the HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test conducted?

The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test involves taking a blood sample from the patient and analyzing it in a laboratory using Luminex X-Map technology. The results of the test are usually reported as a numerical value, indicating the level of antibodies present in the blood. A positive result indicates the presence of HLA antibodies or C1q-fixing antibodies, while a negative result indicates the absence of these antibodies.

Conclusion

The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is an important tool for monitoring the immune response of transplant patients and guiding treatment decisions to prevent rejection of the transplanted organ. It is offered by DNA Labs UAE at a cost of 7960.0 AED. If you require this test, make sure to provide a brief clinical history and HLA typing report of the donor/donors if it is a pre or post transplantation sample.

Test Name HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN Test
Components
Price 7960.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Give brief clinical history and HLA typing report of Donor\/Donors if Pre or Post transplantation sample.
Report Delivery 10-12 days
Method Luminex X-Map technology
Test type Transplantation pathology
Doctor Nephrologist, Hematologist
Test Department:
Pre Test Information Give brief clinical history and HLA typing report of Donor/Donors if Pre or Post transplantation sample.
Test Details

HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is a laboratory test used to detect the presence of specific antibodies in the blood that can cause rejection of transplanted organs. The test measures the level of IgG antibodies against human leukocyte antigen (HLA) class I molecules and screens for the presence of C1q-fixing antibodies. C1q is a protein that binds to IgG antibodies and activates the complement system, leading to tissue damage and rejection of the transplanted organ.

The HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is typically performed before and after organ transplantation to monitor the patient’s immune response to the transplanted organ. If the test shows the presence of high levels of HLA antibodies or C1q-fixing antibodies, it indicates an increased risk of rejection and the need for closer monitoring and treatment.

The test involves taking a blood sample from the patient and analyzing it in a laboratory. The results of the test are usually reported as a numerical value, indicating the level of antibodies present in the blood. A positive result indicates the presence of HLA antibodies or C1q-fixing antibodies, while a negative result indicates the absence of these antibodies.

Overall, the HLA DSA-SAB CLASS I IgG antibodies with C1q screen test is an important tool for monitoring the immune response of transplant patients and guiding treatment decisions to prevent rejection of the transplanted organ.

SKU: TEST-762